Yoshinobu Iwasaki
Kodaira, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Journal: Thoracic cancer
Published: February 11, 2021
Reply to Correspondence: Response to a case report: idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab.
Journal: Respirology case reports
Published: December 08, 2020
Pulmonary embolism after dexamethasone treatment for COVID-19: a case report.
Journal: BMC infectious diseases
Published: November 30, 2020
Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab.
Journal: Respirology case reports
Published: July 10, 2020
Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 01, 2020
A case of pembrolizumab-induced hemophagocytic lymphohistiocytosis successfully treated with pulse glucocorticoid therapy.
Journal: Respiratory medicine case reports
Published: April 21, 2020
A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Journal: The oncologist
Published: October 02, 2018
Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer.
Journal: Investigational new drugs
Published: June 08, 2018
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
Journal: Oncogene
Published: April 10, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026